BSTZ director reports sale of 9,293 BlackRock Science & Tech shares
BlackRock Science & Technology Term Trust reported an insider stock sale by one of its directors.
Rhea-AI Filing Summary
BlackRock Science & Technology Term Trust reported an insider stock sale by one of its directors. The reporting person sold 9,293 shares of common stock on 12/18/2025 at a price of $22.51 per share. On 12/19/2025, the same person reported an additional sale of 0.6469 shares at $22.73 per share. After these transactions, the filing shows the director beneficially owning 0 shares of the trust’s common stock in direct ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 0.6469 | $22.73 | $14.70 |
| Sale | Common Stock | 9,293 | $22.51 | $209K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did BlackRock Science & Technology Term Trust (BSTZ) disclose?
The trust disclosed that a director sold shares of its common stock in two transactions on 12/18/2025 and 12/19/2025.
What is the relationship of the reporting person to BlackRock Science & Technology Term Trust (BSTZ)?
The reporting person is identified as a director of BlackRock Science & Technology Term Trust.
Is this BSTZ insider filing made by one or multiple reporting persons?
The document indicates that the Form 4 is filed by one reporting person, not a group.
AI-generated analysis. How Rhea-AI works. Not financial advice.